Dexmet Vs Lignocaine
Dexmet Vs Lignocaine
Dexmet Vs Lignocaine
DR.D.Y.PATIL MEDICAL COLLEGE HOSPITAL & RESEARCH CENTRE, PUNE
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Background
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Aim of the Study
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Methods and Materials • ASA grade I or II.
• Age between 18 to 65 years.
• Availability of a written and informed consent.
Inclusion • Patients undergoing surgery under general anesthesia
Criteria • Hemodynamically stable patients with all routine investigations
• Single Centre Prospective within normal limits.
Observational Comparative • Duration of surgery less than 3hrs
Study • Pregnant Women
• 60 patients • Patients with heart diseases like congestive heart failure,
• 18-65 year group posted for coronary heart disease, any degree of heart block and
surgery under GA cardiogenic shock
• Patients taking drugs like β‑ blockers,digoxin,α2‑ agonists, Anti-
convulsants or psychotropic medications
Exclusion • Patient with pre-operative heart rate < 45beats/minute
Criteria • Patient with renal insufficiency and liver impairment
• Patient with coagulopathy and psychiatric disorders
• Patient with known allergy to studied drugs
• Patients who required postoperative mechanical Ventilation
• Patient with ASI >II
• Patient unwilling to get enrolled in the study
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Methods and Materials:
1.The institute ethics committee approval
2.pre-anaesthetic evaluation and relevant laboratory investigations.
3.Informed written consent
4.60 patients randomly divided into two groups of 30 each of either sex in age
group of 18-65 years posted for surgery under General Anaesthesia (Computer
generated chart)
5.Dexmedetomidine group and Lignocaine groups were given their respective drug.
1.Group D: Dexmedetomidine group(n=30)will receive bolus dose of 0.5microgm/kg given 10
minutes before extubation.
2.Group L: Lignocaine group (n=30) will receive bolus dose 1.5mg/kg given 10 minutes before
extubation
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Assessment of Hemodynamic parameters
• Parameters assessment
• Non-invasive blood pressure measurement
• Heart rate,
• Oxygen saturation.
• Timeline of assessment
• preoperatively (baseline),
• intra-operatively (for every 15 mins), until the completion of surgery.
• After extubation and full recovery, patients were transferred to the post
anesthesia care unit.
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Hemodynamic parameters after
Bolus inj of DEXMEDETOMIDINE Vs LIGNOCAINE
Pulse SBP DBP MAP RR SPO2
Baseline vitals T0
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Secondary Outcomes
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Airway response under direct laryngoscopy to suction
Grade:
Excellent
Good
Satisfactory
Poor
Very Poor
3. Vomiting
4. Laryngospasm
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Statistical Analysis:
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Demographic Data and Baseline Characteristics:
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
CHANGE IN HEART RATE PER MINUTE
90
80
70
60
HEART RATE
50
40
30
20
10
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
CHANGE IN BLOOD PRESSURE (MAP)
104
102
100
BLOOD PRESSURE mm/Hg
98
96
94
92
90
T2 (After Intubation) T3 (Bolus injection) TE (During Extubation) T4 T5
(15 MINS AFTER EXTUBATION) (30 MINS AFTER EXTUBATION)
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
AIR WAY RESPONSE AT EXTUBATION
20
18
16
14
NUMBER OF PATIENT
12
10
0
GRADE 1 GRADE 2 GRADE 3 GRADE 4 GRADE 5
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Summary of Results
• The demographic profile and baseline characteristics such as HR and MAP,
duration of surgery and duration of anaesthesia between the two groups were
comparable
• Use of dexmedetomidine was associated with less increase in HR as compared to
lignocaine group. Bradycardia occurred in one patient within 1 minute of drug
administration in group D
• MAP was better controlled in the dexmedetomidine group than in lignocaine
group
• Dexmedetomidine group showed better airway response during laryngoscopy
and oral suctioning when compared to Lignocaine group
• The smoothness of extubation was comparable between the two groups
• Both groups had a similar duration of recovery from anesthesia without delay in
emergence
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Dexmedetomidine
• is a potent, alpha-2-selective adrenoceptor agonist
• Actions
• Sympatholytic effect
• Sedative
• Analgesic
• Other features
• Lack of respiratory depression
• Suppression of cough during extubation
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Discussion
• Recovering from anesthesia often results in elevated catecholamine
concentration following anesthetic withdrawal which is further aggravated by
laryngeal manipulation occurring during extubation
• Studies have been carried out with use of diltiazem, lignocaine, esmolol,
labetalol, nicardipine and opioids as sole agent or in comparison with each other
• Dexmedetomidine, a potent alpha-adrenoceptor agonist, decrease the
sympathetic outflow and noradrenergic activity thereby counteracting the
hemodynamic fluctuation occurring at the time of extubation
• Central stimulation of parasympathetic outflow and inhibition of sympathetic
outflow from the locus ceruleous in the brainstem plays a prominent role in the
sedation and anxiolysis produced by dexmedetomidine
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Conclusion
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
References
1. Guler G, Akin A, Tosun Z, Eskitascoglu E, Mizra A, Boyaci A. Single‑dose
dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta
Anaesthesiol Scand 2005;49:1088‑91. 17.
2. Lawrence CJ, De Lange S. Effects of a single pre‑operative dexmedetomidine dose
on isoflurane requirements and peri‑operative haemodynamic stability. Anaesthesia
1997;52:736‑44. 18.
3. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma
concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382‑94. 19.
4. Turan G, Ozgultekin A, Turan C, Dincer E, Yuksel G. Advantageous effects of
Dexmedetomidine on haemodynamic and recovery responses during extubation for
intracranial surgery. Eur J Anaesthesiol2008;25:816‑20. 16.
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses
Thank You
Comparison of Efficacy between Dexmedetomidine and Lignocaine for Attenuation of Extubation Responses